Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ACP3 encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. Additionally we are shipping Acid Phosphatase 3 Antibodies (5) and Acid Phosphatase 3 Proteins (4) and many more products for this protein.
Showing 10 out of 22 products:
Enhanced TDPase and TMPase (show ACPP ELISA Kits) activities may contribute to the reduction of TDP level in AD patients. The results imply that an imbalance of phosphorylation-dephosphorylation related to thiamine and glucose metabolism may be a potential target for AD prevention and therapy.
Thirteen single nucleotide polymorphism (SNPs) in acid phosphatase prostate (ACPP (show ACPP ELISA Kits)) were suggested as candidate causal alleles that underlie ACPP (show ACPP ELISA Kits) regulation and expression.
we have measured the intramolecular diffusion of the full length and 8-residue deletion peptides at two different pHs and found a correlation with fibrillization lag (show STMN1 ELISA Kits) time. These results can be explained by a simple kinetic model of the early stages of aggregation in which oligomerization is controlled by the rate of peptide reconfiguration.
Prostatic acid phosphatase (show ACPP ELISA Kits) delays prostate cancer cell growth in G1 phase of the cell cycle.
Studies suggest that understanding of prostatic acid phosphatase function and regulation of expression will have a significant impact on understanding prostate cancer (PCa) progression and therapy.
Certain factors identified within semen, termed semen-derived enhancers of virus infection (SEVI), fragments of prostatic acid phosphatase (show ACPP ELISA Kits), have been shown to significantly enhance HIV-1 infectivity.
ACPP (show ACPP ELISA Kits) increases significantly in epithelial cells of ovarian carcinoma, which indicates that it may be a candidate biomarker for diagnosis of epithelia-derived ovarian cancer in women.
Data indicate that hypoxia regulates prostatic acid phosphatase (PAP (show ACPP ELISA Kits)) through hypoxia-inducible factor 2 alpha (show EPAS1 ELISA Kits) (HIF2alpha (show EPAS1 ELISA Kits)) and from stimulated A2B (show ADORA2B ELISA Kits) adenosine receptors.
GCNT1 (show GCNT1 ELISA Kits) is over-expressed in prostate cancer and is associated with higher levels of core 2 O-sLe(x) in PSA, PAP (show REG3A ELISA Kits) and MUC1 (show MUC1 ELISA Kits) proteins.
Data indicate that prostate acid phosphatase-based peptide vaccine PAP (show REG3A ELISA Kits)-114-128 peptide appears to be a relevant for the treatment of prostate cancer.
This gene encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. An alternatively spliced transcript variant encoding a longer isoform has been found for this gene. This isoform contains a transmembrane domain and is localized in the plasma membrane-endosomal-lysosomal pathway.
, prostatic acid phosphatase
, prostatic acid phosphotase
, thiamine monophosphatase